Capitalizing on proactive personality over organizational socialization tactics in newcomer learning: A meta-analytic investigation.
Journal of Applied Psychology · 2026
DOI: 10.1037/apl0001351 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Applied Psychology, 2026. Verfasst von Xingyu Pang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Business Administration, School of Business, East China University of Science and Technology. Hauptthemen laut MEDLINE: Personality, Socialization, Organizational Culture, Learning. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Business Administration, School of Business, East China University of Science and Technology.
- Department of Management, May Business School, Texas A&M University.
- Advanced Institute of Business, School of Economics and Management, Tongji University.
- Department of Management, Warrington College of Business, University of Florida.
ORCID-Profile: Xingyu Pang, Jian Liang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Pang, X., Song, Y., Liang, J., & Wang, M. (2026). Capitalizing on proactive personality over organizational socialization tactics in newcomer learning: A meta-analytic investigation. Journal of Applied Psychology. https://doi.org/10.1037/apl0001351
Vancouver
Pang X, Song Y, Liang J, Wang M. Capitalizing on proactive personality over organizational socialization tactics in newcomer learning: A meta-analytic investigation. Journal of Applied Psychology. 2026. doi:10.1037/apl0001351
BibTeX
@article{Pang2026,
author = {Pang, Xingyu and Song, Yifan and Liang, Jian and Wang, Mo},
title = {Capitalizing on proactive personality over organizational socialization tactics in newcomer learning: A meta-analytic investigation},
journal = {Journal of Applied Psychology},
year = {2026},
doi = {10.1037/apl0001351}
}
EUVIMED